Posted this before but the thread got deleted or something? Still looking to keep the discussion of this topic going.
American Journal of Health-System Pharmacy
Current Issue Archive
May 15, 1996, 53:10 > Stability of an extemporaneously... < Previous | Next >
ARTICLE LINKS:
Fulltext
Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
Report
American Journal of Health-System Pharmacy. 53(10):1157-1161, May 15, 1996.
Boulton, David W.; Fawcett, J. Paul; Woods, David J.
Abstract:
The stability of levothyroxine sodium in oral liquid dosage forms compounded from commercially available tablets was studied.
Levothyroxine sodium oral liquids (25 micro gram/mL) were prepared from tablets and from powder with and without methylparaben preservative and transferred to amber, high-density polyethylene bottles. Five bottles of each tablet-based formulation were stored at 2-8 degrees Celsius, 23-27 degrees Celsius, and 38-42 degrees Celsius, and five bottles of each powder-based formulation were stored at 38-42 degrees Celsius. On days 3, 8, 14, 22, 31, 61, and 90, samples were taken from each bottle and analyzed for drug concentration by stability-indicating high-performance liquid chromatography.
There was significant degradation of levothyroxine sodium in all the formulations.However, the tablet-based formulation without preservative stored at 4 degrees Celsius retained at least 90% of its initial concentration for eight days after compounding. Degradation occurred faster in the tablet-based formulation with preservative. None of the formulations retained greater or equal to 90% initial potency by day 14.
An extemporaneous oral liquid formulation of levothyroxine sodium 25 micro gram/mL compounded from crushed tablets was stable for eight days when stored in amber bottles at 4 degrees Celsius.
Am J Health-Syst Pharm. 1996; 53:1157-61.
Copyright (C) 1996 American Society of Health-System Pharmacists, Inc. All rights reserved.
American Journal of Health-System Pharmacy
Current Issue Archive
May 15, 1996, 53:10 > Stability of an extemporaneously... < Previous | Next >
ARTICLE LINKS:
Fulltext
Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
Report
American Journal of Health-System Pharmacy. 53(10):1157-1161, May 15, 1996.
Boulton, David W.; Fawcett, J. Paul; Woods, David J.
Abstract:
The stability of levothyroxine sodium in oral liquid dosage forms compounded from commercially available tablets was studied.
Levothyroxine sodium oral liquids (25 micro gram/mL) were prepared from tablets and from powder with and without methylparaben preservative and transferred to amber, high-density polyethylene bottles. Five bottles of each tablet-based formulation were stored at 2-8 degrees Celsius, 23-27 degrees Celsius, and 38-42 degrees Celsius, and five bottles of each powder-based formulation were stored at 38-42 degrees Celsius. On days 3, 8, 14, 22, 31, 61, and 90, samples were taken from each bottle and analyzed for drug concentration by stability-indicating high-performance liquid chromatography.
There was significant degradation of levothyroxine sodium in all the formulations.However, the tablet-based formulation without preservative stored at 4 degrees Celsius retained at least 90% of its initial concentration for eight days after compounding. Degradation occurred faster in the tablet-based formulation with preservative. None of the formulations retained greater or equal to 90% initial potency by day 14.
An extemporaneous oral liquid formulation of levothyroxine sodium 25 micro gram/mL compounded from crushed tablets was stable for eight days when stored in amber bottles at 4 degrees Celsius.
Am J Health-Syst Pharm. 1996; 53:1157-61.
Copyright (C) 1996 American Society of Health-System Pharmacists, Inc. All rights reserved.

Please Scroll Down to See Forums Below 









